(Q33709697)

28 July 2017

1 reference

title

Intensive treatment for multiple myeloma: where do we stand? (English)

1 reference

28 July 2017

1

Lokhorst HM

1 reference

28 July 2017

Sonneveld P

2

1 reference

PubMed ID

10444158

28 July 2017

Verdonck LF

series ordinal

3

1 reference

PubMed ID

10444158

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

British Journal of Haematology

28 July 2017

1 reference

28 July 2017

106

1 reference

28 July 2017

1

1 reference

28 July 2017

18-27

1 reference

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Idiotypic vaccination in B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Repeat administration of high dose melphalan in relapsed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

Autologous CD34-selected blood progenitor cell transplants for patients with advanced multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01406.X

10.1046/J.1365-2141.1999.01406.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10444158